May 19th, 2023 (Shanghai) — We are glad to announce that Jiguo Zhang, the CEO of ChemPartner PharmaTech, has been invited as a keynote speaker at ACCESS CHINA Boston Forum on June 4th. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
Chempartner is an innovative enterprise (CRO+CDMO) that adheres to the concept of “science first, technology first” and provides integrated pharmaceutical research and development and production services. After years of development,Chempartner has accumulated cutting-edge, diverse, and comprehensive technology, formed a top scientific research talent team, equipped with advanced scientific research facilities, animal experimental facilities, and pharmaceutical intermediate production facilities. It has established research and development and production bases in Zhangjiang/Jinqiao/Lingang, Jiangsu Qidong, Sichuan Chengdu, and San Francisco, USA, and can provide global pharmaceutical enterprises with Biotechnology companies and research institutions provide full lifecycle services for new drugs, covering chemical drug research and development, as well as biopharmaceuticals from early discovery to commercial production.Nowadays,Chempartner has established strategic partnerships with over 150 top global biopharmaceutical research institutions and enterprises; We have provided services to over 3000 global pharmaceutical and biopharmaceutical technology companies, covering the top 20 multinational pharmaceutical companies globally.
睿智医药是一家秉承 “ 科学为本，技术为先”理念、提供医药研发与生产一体化服务的创新型企业（CRO+CDMO）。经过多年的发展，睿智医药拥有前沿、多元且全面的技术积累，组建顶尖的科研人才队伍，配置先进的科研设施、动物实验设施以及医药中间体生产设施，在上海张江/金桥/临港、江苏启东、四川成都和美国旧金山布局研发和生产基地，能够为全球制药企业、生物技术公司以及科研院校提供涵盖化学药研发以及生物药从早期发现到商业化生产的新药全生命周期服务。
About the speaker
Mr. Jeffrey Zhang, CEO of ChemPartner PharmaTech Co., Ltd. Previously, he served as a senior executive at Pfizer, J&J, WuXi, etc. accumulating rich experiences in strategic planning, business development, and business management. Mr. Jeffrey Zhang graduated with honors from Peking University. He is also member of the China Vaccine Industry Association, and honorary president of the China Health Business Development Association (CHBD).
About ACCESS CHINA Boston Forum
“ACCESS CHINA – Boston Forum @BIO” is scheduled to be held on June 4th and June 13th-15th, 2023, in Boston and online, respectively. This event is expected to be the largest Asia-themed gathering during the BIO Convention 2023. The main theme of the forum is “Building Effective Partnerships in Asia: Strategies for Collaboration and Growth”. During the forum, we will cover a range of key topics include drug innovation, market trends, partnership models, and best practices for successful collaborations, etc.
Conference Name: ACCESS CHINA – Boston Forum @BIO
Date & Time: June 4, Sun. (Boston) and June 13-15 (Online)
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 1000 participants Online, 150 participants onsite; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs, investors.
View more information at https://biotochina.org/
“ACCESS CHINA 药通中国-波士顿论坛@BIO”将于2023年6月4-15日在波士顿及线上举行的。此次论坛将是BIO Convention 2023大会期间最大的亚洲主题交流活动。在过去3年时间，药通中国已成功举办13届线上线下活动，帮助近千家公司在药通平台上展出。
大会规模：预计线上1000参会者； 线下150参会者; 100场公司路演
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact: